PATENT CLAIM ANALYSIS

Application Number: 15862934
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "130100"]

Abstract:
The present invention relates to nucleic acids and antibodies against SRPX2 and SRPX2 protein function in angiogenesis. Angiogenesis-related conditions, such as cancer or wound healing, can be treated by the composition comprising the SRPX2 antagonists or agonists, respectively.

Claim (Index 15):
A method of treating an angiogenesis-related condition in a subject comprising administering to the subject an amount of a composition comprising (a) a sequence that hybridizes with an SRPX2 nucleotide sequence selected from the group consisting of SEQ ID NOs:1-10 and inhibits the expression of SRPX2 in a cell, or (b) an antibody or a fragment thereof that binds to an SRPX2 amino acid sequence selected from SEQ ID NOs: 14-23 and inhibits the activity of SRPX2 in angiogenesis, in an amount that is effective to treat the angiogenesis-related condition.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.22857
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13557660', '14158463', '10569744', '13229866', '14185842']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7401553265395984
- 35 USC 102 Novelty (BERT): 0.5274384713027331
- Combined Prediction Score: 0.718883641015912
- Mean Citation Score: 300.343718
- Max Citation Score: 350.86752
- Similarity Product: 250.75436590169912

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test